Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis
JAMA Neurology2017Vol. 74(5), pp. 525–525
Citations Over TimeTop 10% of 2017 papers
Alessandra Gaiani, Ilaria Martinelli, Luca Bello, Giorgia Querin, Marco Puthenparampil, Susanna Ruggero, Elisabetta Toffanin, Annachiara Cagnin, Chiara Briani, Elena Pegoraro, Gianni Sorarú
Abstract
This study confirms the role of NFL as a biomarker in ALS. Elevation in NFL levels in patients with upper motor neuron involvement and FTD might reflect the corticospinal tract degeneration. Low NFL levels in patients with lower motor neuron signs might be a prognostic indicator of milder phenotypes of disease.
Related Papers
- → Phosphorylated TDP-43 aggregates in peripheral motor nerves of patients with amyotrophic lateral sclerosis(2021)46 cited
- → Amyotrophic Lateral Sclerosis Sera Applied to Cultured Motor Neurons(1974)38 cited
- → Negative results of a phase II study of hyperbaric oxygen therapy for amyotrophic lateral sclerosis(2007)6 cited
- → Genetics of Amyotrophic Lateral Sclerosis(2014)4 cited
- Diagnosis and Treatment of Amyotrophic Lateral Sclerosis(2011)